院外心脏骤停后目标温度管理患者的休克严重程度与院内死亡率
该回顾性队列研究纳入2005年12月至2016年9月间因推测心源性病因发生OHCA并接受TTM的268例成年患者,采用多因素logistic回归分析院内死亡的预测因素。结果显示院内死亡104例(38.8%);初始乳酸每升高1 mmol/L的校正OR为1.15(95%CI 1.00-1.31,P=0.03),峰值VIS每升高10单位的校正OR为1.20(95%CI 1.10-1.54,P=0.003),均与院内死亡独立相关;24小时平均动脉压作为连续变量无显著关联(P=0.92),但mMAP<70 mmHg者校正后院内死亡风险仍更高(校正OR 9.30,95%CI 1.39-62.02,P=0.02)。作者结论认为,以乳酸水平、mMAP<70 mmHg及前24小时血管活性药物需求反映的休克严重程度与院内死亡率升高相关。
要点
- OHCA后接受TTM的患者中,前24小时mMAP<70 mmHg与院内死亡独立相关(校正OR 9.30,95%CI 1.39-62.02,P=0.02)。
- 初始乳酸每升高1 mmol/L,院内死亡校正OR 1.15(95%CI 1.00-1.31,P=0.03)。
- 前24小时峰值VIS每升高10单位,院内死亡校正OR 1.20(95%CI 1.10-1.54,P=0.003)。
- 24小时平均动脉压作为连续变量与院内死亡无显著关联(P=0.92)。
- 研究队列中60%的患者在前24小时需要血管升压药,院内死亡率为38.8%。
适用人群与场景
- 2005年12月至2016年9月间因推测心源性病因发生院外心脏骤停并接受目标温度管理的成年患者。
- 队列中89%为目击下骤停,87%为可除颤心律,64%接受旁观者心肺复苏。
研究设计与关键结果
- 回顾性队列研究,纳入268例成年OHCA后接受TTM的患者,中位年龄64(55,71.8)岁,女性占27%。
- 院内死亡104例(38.8%);前24小时需要血管升压药者占60%。
- 初始乳酸每升高1 mmol/L与院内死亡独立相关(校正OR 1.15,95%CI 1.00-1.31,P=0.03)。
- 前24小时峰值VIS每升高10单位与院内死亡独立相关(校正OR 1.20,95%CI 1.10-1.54,P=0.003)。
- 24小时平均动脉压作为连续变量与院内死亡无显著关联(P=0.92)。
- mMAP<70 mmHg者院内死亡风险更高(校正OR 9.30,95%CI 1.39-62.02,P=0.02)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于OHCA后接受TTM的患者,前24小时应关注初始乳酸水平、峰值VIS及平均动脉压,以识别院内死亡风险较高的患者。
- 作者认为,以乳酸水平、mMAP<70 mmHg及前24小时血管活性药物需求反映的休克严重程度与院内死亡率升高相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Shock in patients resuscitated after out of hospital cardiac arrest (OHCA) is associated with an increased risk of mortality. We sought to determine the associations between lactate level, mean arterial pressure (MAP), and vasopressor/inotrope doses with mortality.
METHODS: Retrospective cohort study of adult patients with OHCA of presumed cardiac etiology treated with targeted temperature management (TTM) between December 2005 and September 2016. Multivariable logistic regression was performed to determine predictors of hospital death.
RESULTS: Among 268 included patients, the median age was 64 (55, 71.8) years, including 27% females. OHCA was witnessed in 89%, OHCA rhythm was shockable in 87%, and bystander CPR was provided in 64%. Vasopressors were required during the first 24 h in 60%. Hospital mortality occurred in 104 (38.8%) patients. Higher initial lactate, peak Vasoactive-Inotropic Score (VIS), and lower mean 24-h MAP were associated with higher hospital mortality (all P < 0.001). After multivariable regression, both higher initial lactate (adjusted OR 1.15 per 1 mmol/L higher, 95% CI 1.00-1.31, P = 0.03) and higher peak VIS (adjusted OR 1.20 per 10 units higher, 95% CI 1.10-1.54, P = 0.003) were associated with higher hospital mortality, but mMAP was not (P = 0.92). However, patients with a mMAP < 70 mm Hg remained at higher risk of hospital mortality after multivariable adjustment (adjusted OR 9.30, 95% CI 1.39-62.02, P = 0.02).
CONCLUSIONS: In patients treated with TTM after OHCA, greater shock severity, as reflected by higher lactate levels, mMAP < 70 mmHg, and higher vasopressor requirements during the first 24 h was associated with an increased rate of hospital mortality.
参考来源
- Tabi M, Burstein BJ, Ahmed A, et al. Shock Severity and Hospital Mortality In Out of Hospital Cardiac Arrest Patients Treated With Targeted Temperature Management. Shock. 2021. PMID: 32769819. doi:10.1097/SHK.0000000000001600
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。